Walleye Capital’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$350K Buy
19,200
+10,700
+126% +$213K ﹤0.01% 4385
2026
Q2
$192K Buy
+8,500
New +$213K ﹤0.01% 3528
2026
Q1
– Sell
-17,000
Closed -$535K – 4850
2025
Q4
$535K Buy
17,000
+6,500
+62% +$216K ﹤0.01% 2923
2025
Q3
$375K Buy
10,500
+8,500
+425% +$388K ﹤0.01% 2832
2025
Q2
$115K Sell
2,000
-400
-17% -$22.6K ﹤0.01% 3704
2025
Q1
$140K Buy
2,400
+700
+41% +$47.8K ﹤0.01% 3466
2024
Q4
$137K Buy
1,700
+300
+21% +$25.6K ﹤0.01% 3975
2024
Q3
$112K Sell
1,400
-9,300
-87% -$661K ﹤0.01% 4351
2024
Q2
$654K Buy
10,700
+4,300
+67% +$256K ﹤0.01% 3263
2024
Q1
$316K Buy
+6,400
New +$305K ﹤0.01% 3619

Other funds holding PRCT

Walleye Capital's PRCT Position: Q3 2026 in Review

Walleye Capital increased its Procept Biorobotics (PRCT) stake by 872% in Q3 2026, buying an estimated $92.5K and bringing the position to 5,173 shares worth $94.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5218.

Walleye Capital first reported a position in PRCT in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.77M in Q2 2024. 232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Walleye Capital held 5,173 shares of Procept Biorobotics worth $94.3K as of Q3 2026.
  • Walleye Capital bought 4,641 Procept Biorobotics shares in Q3 2026, an estimated $92.5K.
  • Procept Biorobotics made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5218 holding.
  • Walleye Capital first reported a position in Procept Biorobotics in Q4 2023 and has held it in 8 quarters since.
  • Walleye Capital's Procept Biorobotics position peaked at $2.77M in Q2 2024.
  • 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.